| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/05/2007 | US7226597 Vaccine for humans, animals; forming antibodies; genetic engineering; mutant polypeptide |
| 06/05/2007 | US7226596 Metalloenzymes; antiproliferative agents; anticarcinogenic agents; cancer diagnosis; antisense agents; complementary determining regions |
| 06/05/2007 | US7226595 Conjugated antigen for use as tool in the treatment of cancer |
| 06/05/2007 | US7226593 Methods of treating cachexia with chimeric anti-TNF antibodies |
| 06/05/2007 | US7226591 Nucleotide sequences coding protein for use in the prevention and treatment of pancreatitis |
| 06/05/2007 | US7226590 Antimicrobial composition |
| 06/05/2007 | US7226587 To promote osteogenesis and therefore uses include fracture healing and repair and acceleration of fracture healing |
| 06/05/2007 | CA2273823C Polypeptides encoded by a human lipase-like gene, compositions and methods |
| 06/05/2007 | CA2258990C Use of oxidized cellulose and complexes thereof for chronic wound healing |
| 06/05/2007 | CA2243577C Methods for purification and use of erythropoietin binding protein |
| 06/05/2007 | CA2214431C Human vegf-specific antisense oligonucleotides |
| 06/05/2007 | CA2181165C Anti-fungal methods and materials |
| 06/05/2007 | CA2143442C Dorsal tissue affecting factor and compositions |
| 05/31/2007 | WO2007062376A2 Selective inhibition of matrix metalloproteinases |
| 05/31/2007 | WO2007062327A2 Releasable wire connector |
| 05/31/2007 | WO2007062060A2 Methods and compositions using substance p to promote wound healing |
| 05/31/2007 | WO2007061942A2 Compositions for disrupting and inhibiting reconstitution of wound biofilm |
| 05/31/2007 | WO2007061939A2 Metabolite derivatives of the hdac inhibitor fk228 |
| 05/31/2007 | WO2007061924A2 Methods of treating cartilage defects |
| 05/31/2007 | WO2007061873A1 High-potency sweetener for weight management and compositions sweetened therewith |
| 05/31/2007 | WO2007061829A2 Pharmaceutical composition |
| 05/31/2007 | WO2007061657A2 Interleukin-10 compositions for the treatment of adenocarcinomas |
| 05/31/2007 | WO2007061434A2 A pharmaceutical formulation of glp-1 and its use for treating a metabolic syndrome |
| 05/31/2007 | WO2007061256A1 Novel use of ubiquitin c-terminal hydrolase-l1 |
| 05/31/2007 | WO2007061168A1 Pharmaceutical compositions for cell therapy of pigmentation disorders |
| 05/31/2007 | WO2007060979A1 Lipopolysaccharide- or lipid a-binder, and novel peptide |
| 05/31/2007 | WO2007060918A1 Novel memory ctl induction potentiator |
| 05/31/2007 | WO2007060886A1 Therapeutic agent for neurodegenerative disease |
| 05/31/2007 | WO2007060769A1 Lipopolysaccharide or lipid a binder and novel peptide |
| 05/31/2007 | WO2007060747A1 Galectin-9 induction factor |
| 05/31/2007 | WO2007060453A1 Promoting wound healing by administering a prostaglandin e and granulocyte-macrophage colony stimulating factor |
| 05/31/2007 | WO2007060425A1 Thrombospondin domain-containing cell surface recognition molecules |
| 05/31/2007 | WO2007060423A1 Signal anchored protein |
| 05/31/2007 | WO2007059956A1 Agent for use in the case of disorders of blood sugar metabolism, including diabetes |
| 05/31/2007 | WO2007059625A1 Bacterial antigens and uses thereof |
| 05/31/2007 | WO2007059574A1 A molecule and chimeric molecules thereof |
| 05/31/2007 | WO2007059569A1 Compositions and methods for treatment of diabetes |
| 05/31/2007 | WO2007044059A9 Electromagnetic treatment apparatus for augmenting wound repair and method for using same |
| 05/31/2007 | WO2007042524A3 Treating diabetes using inhibitors of il-1 |
| 05/31/2007 | WO2007041439A9 Centrosomal proteins, nucleic acids and method of use thereof |
| 05/31/2007 | WO2007039254A3 Use of fusion proteins for the prevention or the treatment of pathologies resulting from ischemia |
| 05/31/2007 | WO2007038386A8 Method for enhancing immune responses in mammals |
| 05/31/2007 | WO2007037514A9 Novel application of heparin-binding epidermal growth factor-like growth factor for medical purposes |
| 05/31/2007 | WO2007036033A8 Oligodendrocyte precursor cell proliferation regulated by prolactin |
| 05/31/2007 | WO2007033233A3 Stimulating g protein-coupled receptors |
| 05/31/2007 | WO2007028632A3 Analogs of gastric inhibitory polypeptide as a treatment for age related decreased pancreatic beta cell function |
| 05/31/2007 | WO2007025219A3 Nogo receptor polypeptides and polypeptide fragments and uses thereof |
| 05/31/2007 | WO2007020672A3 Use of nerve growth factor in eye-drops for therapy of pathologies of the central nervous system, such as alzheimer's and parkinson's disease |
| 05/31/2007 | WO2007019549A3 Composition and method for use in cartilage affecting conditions |
| 05/31/2007 | WO2007019302A3 Treatment of cardiac hypertrophy by activation of ciliary neurtrophic factor receptor |
| 05/31/2007 | WO2007016600A3 Method of preserving the function of insulin-producing cells |
| 05/31/2007 | WO2007010258A3 Polymorphism in cysteine dioxygenase |
| 05/31/2007 | WO2007008657A3 Hepatitis c virus inhibitors |
| 05/31/2007 | WO2007006041A3 Imaging and therapeutic method using monocytes |
| 05/31/2007 | WO2007001361A3 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 05/31/2007 | WO2006136419B1 Use of urokinase inhibitors for the treatment and/or prevention of neuropathological diseases |
| 05/31/2007 | WO2006136374A3 Use of gip and/or vitamin d3 analogues thereof for enhancing stem or progenitor cell differentiation into insulin producing cells |
| 05/31/2007 | WO2006133457A3 Bone morphogenetic variants, compositions and methods of treatment |
| 05/31/2007 | WO2006131347A3 Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection |
| 05/31/2007 | WO2006127900A3 Tl1a in the treatment of disease |
| 05/31/2007 | WO2006120019A3 Mcm9, a member of the mcm2-8 family and its use in pharmaceutical compositions |
| 05/31/2007 | WO2006119363A3 Mutations in oas1 genes |
| 05/31/2007 | WO2006105501A3 Control of blood glucose in diabetes treatment using pulmonarily administered insulin in combination with basal insulin |
| 05/31/2007 | WO2006102457A3 Use of fibrous tissue inducing proteins for hernia repair |
| 05/31/2007 | WO2006099516A3 Methods for magnetic resonance imaging |
| 05/31/2007 | WO2006093947A3 Semi-synthetic glycopeptides with antibiotic activity |
| 05/31/2007 | WO2006078463A3 Method for treating cardiovascular disease |
| 05/31/2007 | WO2006074370A3 Agonists and antagonists of tnfrii/cd120b for treatment of immune-related diseases |
| 05/31/2007 | WO2006056889A3 Method and composition for enhancing anti-angiogenic therapy |
| 05/31/2007 | WO2006052911A3 Laforin expression in diagnosis and treatment of cancer and other diseases |
| 05/31/2007 | WO2006047716A3 Use of diindolylmethane-related indoles and growth factor receptor inhibitors for the treatment of human cytomegalovirus associated disease |
| 05/31/2007 | WO2006041835A3 Methods of inhibiting cell death or inflammation in a mammal |
| 05/31/2007 | WO2006039707A3 Domain ii mutants of anthrax lethal factor |
| 05/31/2007 | WO2006037984A3 Treatment of cancer |
| 05/31/2007 | WO2006033854A3 Aptamers to von willebrand factor and their use as thrombotic disease therapeutics |
| 05/31/2007 | WO2006031353A3 Vascular endothelial growth factor fusion constructs and uses thereof |
| 05/31/2007 | WO2006010155A8 Gonadotropin releasing hormone antagonists |
| 05/31/2007 | WO2006004593A3 Method for preventing and treating mast cell mediated diseases |
| 05/31/2007 | WO2005117940A3 Cell death modulation via antagonists of fasl and fas activation |
| 05/31/2007 | WO2005115437A3 Methods for affecting body composition |
| 05/31/2007 | WO2005089106A3 Degradable nanoparticles |
| 05/31/2007 | WO2005070138A3 O-linked glycosylation of peptides |
| 05/31/2007 | WO2005058930A3 Methods for production of recombinant vascular endothelial cell growth inhibitor |
| 05/31/2007 | WO2005048918A3 Anthrax vaccine |
| 05/31/2007 | WO2005032483A3 Polysaccharides for pulmonary delivery of active agents |
| 05/31/2007 | US20070124838 Expression of the human igf-1 in transgenic plastids |
| 05/31/2007 | US20070124825 Use of hepcidin as a regulator of iron homeostasis |
| 05/31/2007 | US20070123696 G-csf conjugates |
| 05/31/2007 | US20070123483 Method and composition for treating obesity by targeting cathespin |
| 05/31/2007 | US20070123481 Antisense IAP oligonucleotides and uses thereof |
| 05/31/2007 | US20070123470 Enhancement of growth hormone levels with a dipeptidyl peptidase IV inhibitor and a growth hormone secretagogue |
| 05/31/2007 | US20070123469 Cyclic and linear oligopeptides; capable of increasing gap junction conductance; lack the proarrhythmic side effects; use as drug to also treat eye disorders, cancer, and gastrointestinal disorders among others |
| 05/31/2007 | US20070123468 Prodrugs of active agents |
| 05/31/2007 | US20070123467 Amniotic-derived peptide and uses thereof |
| 05/31/2007 | US20070123466 Method of treating recurrent miscarriages |
| 05/31/2007 | US20070123465 Oligomeric peptides and their use for the treatment of hiv infections |
| 05/31/2007 | US20070123464 Methods and reagents for treating inflammation and fibrosis |
| 05/31/2007 | US20070123463 screening for drugs that reduce or enhance sensitivity to insulin and/or leptin, thereby modulating carbohydrate metabolism such as increasing or decreasing blood glucose levels, glucose uptake into cells and assimilation into glycogen; dietetics and antidiabetic agents |
| 05/31/2007 | US20070123462 Effects of tissue transglutaminase on beta-amyloid-induced apoptosis |
| 05/31/2007 | US20070123461 Reproductive management |